#Regeneron
During the Covid-19 pandemic, Trump was notably one of the first people administered an antibody treatment from Regeneron after he contracted the virus, via this same compassionate use pathway.
June 23, 2026 at 12:27 PM
BREAKING: Regeneron Pharmaceuticals, a large biotech company, is buying 23andMe.
May 19, 2025 at 3:29 PM
The treatment, developed by Regeneron Pharmaceuticals, is for a very rare form of deafness. But it represents a medical milestone. n.pr/4sR4fyc
The FDA gives the green light to the first gene therapy for deafness
The treatment, developed by Regeneron Pharmaceuticals, is for a very rare form of deafness. But it represents a medical milestone.
n.pr
April 23, 2026 at 9:34 PM
Getting Tubi ads for a company called Regeneron and I feel like I’m watching an opening sequence cutscene in an imsim
July 15, 2026 at 5:14 AM
Not often I advertise a new blog. But this guy (whoever he may be) very elegantly gives the case for Regeneron.

$REGN

notesfromthebeautycontest.substack.com/p/regeneron-...
Regeneron Pharmaceuticals (REGN)
A Deep Dive
notesfromthebeautycontest.substack.com
March 18, 2025 at 1:36 AM
Health Rounds: Regeneron drug wipes out residual multiple myeloma cells in small trial reut.rs/3Mwo2nh
Health Rounds: Regeneron drug wipes out residual multiple myeloma cells in small trial
A recently approved antibody drug from Regeneron Pharmaceuticals eradicates residual traces of multiple myeloma after initial treatments, potentially allowing patients to avoid grueling bone marrow transplants, preliminary data from a small mid-stage trial suggest.
reut.rs
December 10, 2025 at 11:25 PM
23andMe sold the genetic data of 15 million people for $256 million to a pharmaceutical company called Regeneron.

🔗 www.404media.co/23andme-sale...
May 21, 2025 at 5:25 PM
Biotechnology company Regeneron Pharmaceuticals is buying 23andMe for $256 million, two months after the genetic testing company filed for Chapter 11 bankruptcy protection.
Biotechnology company Regeneron buying 23andMe for $256 million
Biotechnology company Regeneron Pharmaceuticals is buying 23andMe for $256 million, two months after the genetic testing company filed for Chapter 11 bankruptcy protection.
bit.ly
May 19, 2025 at 10:00 PM
Too bad he didn’t run away from Regeneron antibodies when his oxygen saturation was in the 70s.
March 17, 2025 at 1:59 AM
Regeneron to buy bankrupt genetic testing firm 23andMe for $256 million reut.rs/4mFheBx
Regeneron to buy bankrupt genetic testing firm 23andMe for $256 million
Drugmaker Regeneron Pharmaceuticals will buy genetic testing firm 23andMe Holding for $256 million through a bankruptcy auction, the companies said on Monday.
reut.rs
May 19, 2025 at 11:50 AM
Regeneron, $REGN, agrees to buy bankrupt 23andMe for $256 million, promises ethical use of customers' DNA data
May 19, 2025 at 10:17 PM
Had a chance to chat with Akilan Sankaran from Albuquerque, a top 40 finalist in this year’s Regeneron Science Talent Search–our nation’s oldest and most prestigious STEM competition for high school seniors. Congrats, Akilan!
March 13, 2025 at 1:43 PM
The FDA has approved the first gene therapy for genetic hearing loss, which drugmaker Regeneron
says it will offer for free to U.S. patients.
FDA approves first gene therapy for genetic hearing loss
In an unusual move, the drugmaker Regeneron is making the treatment available for free to patients in the United States.
nbcnews.to
April 23, 2026 at 10:40 PM
“Regeneron takes Klarna” is my new “cellar door”
July 15, 2026 at 5:22 AM
Pharma and healthcare jets at IAD today:

Regeneron – N787DV

Humana – N733K

Pfizer – N6CP & N3CP

McKesson – N714K

Additionally N628TS, Elon Musk
November 11, 2025 at 9:05 PM
FYI: under capitalism your DNA is worth $17

www.404media.co/23andme-sale...
23andMe Sale Shows Your Genetic Data Is Worth $17
23andMe sold the genetic data of 15 million people for $256 million to a pharmaceutical company called Regeneron.
www.404media.co
May 19, 2025 at 4:53 PM
Trump-aligned biotech firm is buying 23andMe, which is a good reminder to revoke and rotate your genomic data for security and privacy purposes!

www.cnn.com/2025/05/19/b...
Regeneron to buy bankrupt DNA testing firm 23andMe for $256 million | CNN Business
Drugmaker Regeneron Pharmaceuticals will buy genetic testing firm 23andMe for $256 million through a bankruptcy auction, the companies said Monday.
www.cnn.com
May 19, 2025 at 3:28 PM
Re Trump’s promise for free IVF:

Campaigning for the ‘16 election, Trump promised universal health care, with the government paying for it. Never happened (obv)

After he recovered from Covid in ‘20 he promised free regeneron antibody treatment to everybody. Never happened (obv)
September 1, 2024 at 3:51 AM
President Donald Trump on Thursday announced a deal with drugmaker Regeneron to lower the cost of its pharmaceutical products as part of the White House's signature drug pricing initiative.
https://to.pbs.org/4mKvB7I
WATCH: Trump unveils deal with Regeneron to lower its drug prices for Medicaid
President Donald Trump on Thursday announced a deal with drugmaker Regeneron to lower the cost of its pharmaceutical products as part of the White House's signature drug pricing initiative.
www.pbs.org
April 23, 2026 at 11:31 PM
Regeneron drops after skin cancer treatment fails late-stage trial reut.rs/4dUl3zd
Regeneron drops after skin cancer treatment fails late-stage trial
Regeneron's shares fell 12% in morning trade on Monday after the company's experimental ​treatment missed the main goal in a late-stage trial for patients with a ‌type of skin cancer.
reut.rs
May 18, 2026 at 2:45 PM
👌News about a new #LongCovid monoclonal antibody trial coming in Jan 2025 by legend Prof Nancy Klimas 🧪

From a start of 3 case studies who recovered from Regeneron. Now Evushield has stepped in & FDA approval has been given with a rapid review 🥳
December 8, 2024 at 4:15 PM
23andMe (and the genomic data for 15 million people) was sold for the bargain-basement price $256 million
23andMe sells its most valuable asset to biotech company Regeneron, which promises to keep your DNA private
Regeneron said it will continue uninterrupted service of 23andMe’s consumer genome services after its purchase closes as expected in the third quarter of this year.
www.marketwatch.com
May 19, 2025 at 11:10 PM